KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation

Virology

Volumn 448, Issue , 2014, Pages 293-302

  Bentz, Gretchen L ^a   Bheda Malge, Anjali ^a   Wang, Ling ^a   Shackelford, Julia ^a   Damania, Blossom ^a,b   Pagano, Joseph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

EBV; KSHV; LANA; LMP1; UCH L1

Indexed keywords

IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENT MEMBRANE PROTEIN 1; RNA; UBIQUITIN THIOLESTERASE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UCH L1 GENE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VIRUS LATENCY; VIRUS TRANSFORMATION;

EID: 84887394829     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.018     Document Type: Article

References (61)

1. Ballestas M.E., Kaye K.M. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol. 2011, 6(12):1399-1413.
2. Basseres E., Coppotelli G., Pfirrmann T., Andersen J.B., Masucci M., Frisan T. The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton. Cell. Microbiol. 2010, 12:1622-1633.
3. Bentz G.L., Shackelford J., Pagano J.S. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J. Virol. 2012, 86:12251-12261.
4. Bentz G.L., Whitehurst C.B., Pagano J.S. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J. Virol. 2011, 85:10144-10153.
5. Betarbet R., Sherer T.B., Greenamyre J.T. Ubiquitin-proteasome system and Parkinson's diseases. Exp. Neurol. 2005, 191(Suppl. 1):S17-27.
6. Bheda A., Gullapalli A., Caplow M., Pagano J.S., Shackelford J. Ubiquitin editing enzyme UCH L1 and microtubule dynamics: implication in mitosis. Cell Cycle 2010, 9:980-994. (Georgetown, Tex).
7. Bheda A., Shackelford J., Pagano J.S. Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes. PloS one 2009, 4:e6764.
8. Bheda A., Yue W., Gullapalli A., Shackelford J., Pagano J.S. PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells. Leuk. Lymphoma 2011, 52:1336-1347.
9. Bheda A., Yue W., Gullapalli A., Whitehurst C., Liu R., Pagano J.S., Shackelford J. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PloS one 2009, 4:e5955.
10. Bornkamm G.W. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin. Cancer Biol. 2009, 19:351-365.
11. Callahan J., Pai S., Cotter M., Robertson E.S. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Virology 1999, 262:18-30.
12. Carbone A., Cilia A.M., Gloghini A., Capello D., Perin T., Bontempo D., Canzonieri V., Tirelli U., Volpe R., Gaidano G. Primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Leuk. lymphoma 2000, 36:447-456.
13. Carbone A., Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br. J. Haematol. 2005, 130:662-670.
14. Fakhari F.D., Jeong J.H., Kanan Y., Dittmer D.P. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J. Clin. Invest. 2006, 116:735-742.
15. Fan H., Kim S.C., Chima C.O., Israel B.F., Lawless K.M., Eagan P.A., Elmore S., Moore D.T., Schichman S.A., Swinnen L.J., Gulley M.L. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J. Med. Virol. 2005, 75:59-69.
16. Fan W., Bubman D., Chadburn A., Harrington W.J., Cesarman E., Knowles D.M. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J. Virol. 2005, 79:1244-1251.
17. Freiborg J., Kong W., Hottinger M.O., Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999, 402(6764):889-894.
18. Fujimuro M., Hayward S.D., Yokosawa H. Molecular piracy: manipulation of the ubiquitin system by Kaposi's sarcoma-associated herpesvirus. Rev. Med. Virol. 2007, 17:405-422.
19. Garber A.C., Shu M.A., Hu J., Renne R. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol. 2001, 75(17):7882-7892.
20. Groves A.K., Cotter M.A., Subramanian C., Robertson E.S. The latency-associated nuclear antigen encoded by Kaposi's Sarcoma-Associated herpesvirus activates two major essential Epstein-Barr virus latent promoters. J. Virol. 2001, 75:9446-9457.
21. Groves A.K., Cotter M.A., Subramanian C., Robertson E.S. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters. J. Virol. 2001, 75:9446-9457.
22. Hatzivassiliou E., Mosialos G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci. 2002, 7:d319-329.
23. Hibi K., Westra W.H., Borges M., Goodman S., Sidransky D., Jen J. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am. J. Pathol. 1999, 155:711-715.
24. Holowaty M.N., Frappier L. HAUSP/USP7 as an Epstein-Barr virus target. Biochem. Soc. Trans. 2004, 32:731-732.
25. Holowaty M.N., Sheng Y., Nguyen T., Arrowsmith C., Frappier L. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 2003, 278:47753-47761.
26. Jang K.L., Shackelford J., Seo S.Y., Pagano J.S. Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. USA 2005, 102:18431-18436.
27. Jeong J.H., Orvis J., Kim J.W., McMurtrey C.P., Renne R., Dittmer D.P. Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 2004, 279(16):16822-16831.
28. Kabuta T., Setsuie R., Mitsui T., Kinugawa A., Sakurai M., Aoki S., Uchida K., Wada K. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum. Mol. Genet. 2008, 15:1482-1496.
29. Kaul R., Murakami M., Choudhuri T., Robertson E.S. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J. Virol. 2007, 81:10352-10361.
30. Kim H.J., Kim Y.M., Lim S., Nam Y.K., Jeong J., Kim H.J., Lee K.J. Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 2009, 28:117-127.
31. Krithivas A., Young D.B., Liao G.L., Greene D., Hayward S.D. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 2000, 74:9637-9645.
32. Kwon J., Wang Y.L., Setsuie R., Sekiguchi S., Sakurai M., Sato Y., Lee W.W., Ishii Y., Kyuwa S., Noda M., Wada K., Yoshikawa Y. Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice. Biol. Reprod. 2004, 71:515-521.
33. Lam N., Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 2003, 15:9-16.
34. Larsen C.N., Price J.S., Wilkinson K.D. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 1996, 35:6735-6744.
35. Li H.P., Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 2003, 10:490-504.
36. Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002, 111:209-218.
37. Loeffler-Ragg J., Skvortsov S., Sarg B., Skvortsova I., Witsch-Baumgartner M., Mueller D., Lindner H., Zwierzina H. Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines. Eur. J. Cancer 2005, 41:2338-2346.
38. Long E.M., Long M.A., Tsirigotis M., Gray D.A. Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor. Lung Cancer 2003, 42:9-21.
39. Miyoshi Y., Nakayama S., Torikoshi Y., Tanaka S., Ishihara H., Taguchi T., Tamaki Y., Noguchi S. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci. 2006, 97:523-529.
40. Ning S., Campos A.D., Darnay B.G., Bentz G.L., Pagano J.S. TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol. Cell Biol. 2008, 28:6536-6546.
41. Ning S., Pagano J.S. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J. Virol. 2010, 84:6130-6138.
42. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 2003, 12:1945-1958.
43. Otsuki T., Yata K., Takata-Tomokuni A., Hyodoh F., Miura Y., Sakaguchi H., Hatayama T., Hatada S., Tsujioka T., Sato Y., Murakami H., Sadahira Y., Sugihara T. Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Br. J. Haematol. 2004, 127:292-298.
44. Ovaa H., Kessler B.M., Rolen U., Galardy P.J., Ploegh H.L., Masucci M.G. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc. Natl. Acad. Sci. USA 2004, 101:2253-2258.
45. Pagano J. EBV Diseases, in Damania and Pipas (ed) DNA Tumor Viruses 2009, Springer Sciences+Business Media, New York, NY, p 217-240.
46. Paudel N., Sadagopan S., Balasubramanian S., Chandran B. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells. J Virol. 2012, 86(3):1589-1607.
47. Petre C.E., Sin S.H., Dittmer D.P. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. J. Virol. 2007, 81:1912-1922.
48. Rolen U., Freda E., Xie J.J., Pfirrmann T., Frisan T., Masucci M.G. The ubiquitin C-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation. J. Cell. Mol. Med. 2009, 13:1666-1678.
49. Saha A., Murakami M., Kumar P., Bajaj B., Sims K., Robertson E.S. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J. Virol. 2009, 83:4652-4669.
50. Setsuie R., Wada K. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 2007, 51:105-111.
51. Shackelford J., Pagano J.S. Targeting of host-cell ubiquitin pathways by viruses. Essays in Biochem. 2005, 41:139-156.
52. Shackelford J., Pagano J.S. Role of the ubiquitin system and tumor viruses in AIDS-related cancer. BMC Biochem. 2007, 8(Suppl. 1):S8.
53. Sin S.H., Roy D., Wang L., Staudt M.R., Fakhari F.D., Patel D.D., Henry D., Harrington W.J., Damania B.A., Dittmer D.P. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 2007, 109:2165-2173.
54. Soni V., Cahir-McFarland E., Kieff E. LMP1 TRAFficking activates growth and survival pathways. Adv. Exp. Med. Biol 2007, 597:173-187.
55. Verma S.C., Lan K., Robertson E. Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol. 2007, 312:101-136.
56. Wang L., Dittmer D.P., Tomlinson C.C., Fakhari F.D., Damania B. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 2006, 66:3658-3666.
57. Wen Y., Eng C.H., Schmoranzer J., Cabrera-Poch N., Morris E.J., Chen M., Wallar B.J., Alberts A.S., Gundersen G.G. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat. Cell Biol. 2004, 6:820-830.
58. Xu D.S., Coleman T., Zhang J., Fagot A., Kotalik C., Zhao L.J., Trivedi P., Jones C., Zhang L.W. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas. J. Virol. 2007, 81:6068-6078.
59. Yang Y.C., Li X., Chen W. Characterization of genes associated with different phenotypes of human bladder cancer cells. Acta Biochim. Biophys. Sin. (Shanghai) 2006, 38:602-610.
60. Ying H., Xiao Z.X. Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 2006, 5:506-508. (Georgetown, Tex).
61. Zheng H., Li L.L., Hu D.S., Deng X.Y., Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell. Mol. Immunol. 2007, 4:185-196.